Additional Information
Market: TSX-V
Sector: Manufacturing
EPIC: BXI
1 year chart
1 day chart
Bioexx Specialty Proteins
www.bioexx.com
BioExx Specialty Proteins Ltd. is a capital pool company. As of December 31, 2010, the Company produced two primary products: canola oil and canola meal, focused on expanding the product line in 2011 to include concentrated forms of canola protein

BioExx price target downgraded 90% by Stonecap Securities

16th Nov 2011, 10:58 am by Olivia D'Orazio
BioExx price target downgraded 90% by Stonecap Securities

BioExx Specialty Proteins (TSE:BXI) on Wednesday saw its target price downgraded 90 percent by Stonecap Securities, citing weak operations at the company's main production facility.

Stonecap analyst, Michael Goldberg, CFA, lowered BioExx's target stock price to $0.25 per share, from $2.50 per share previously, and downgraded the company's rating to 'sector perform', from 'outperform'.

In Toronto, BioExx stock closed at $0.17 per share on Tuesday.

After a series of delays and operating setbacks, BioExx is currently producing only 1.2 tonnes of Isolexx per week, representing two percent of its total capacity, Stonecap said. The equity research firm said it had expected a break-even utilization of 70 percent.

"We believe the probability of achieving commercial production under the current operating strategy is now materially lower than first estimated," Goldberg said in a statement.

BioExx reported its third quarter results on Tuesday, which Stonecap said was in line with expectations. For the three months ending September 30, BioExx widened its net loss to $5.75 million, or $0.03 loss per share, from $3.04 million, or $0.02 loss per share, a year ago.

Revenues spiked to $930,239, from $178,464 in the same period last year, based on 2.0 billion tonnes of seed processed during the quarter, compared to 500 million tonnes in the year-ago period.

BioExx also announced the appointment of CFO and interim CEO, Chris Schnarr, to the position of CEO.

Schnarr confirmed management's intention of curbing the building and operation of future protein production plants, to instead search for a strategic partner with better access to capital, infrastructure, and market presence in order to move forward.

Stonecap said that, in a conference call, BioExx indicated it has had some discussions with various parties.

Goldberg continued: "We believe that shareholder value is likely to be surfaced through some form of residual interest in the future value of the production process once it can be optimized."

BioExx is focused on the separation of oil and high-value proteins from oilseeds for global food, beverage, and nutrition markets, among others. Its proprietary technologies use lower temperatures in the separation process, resulting in a higher-quality protein.

As of 9:42 am EDT, BioExx shares were down 2.94 percent to $0.165.

No investment advice


Proactive Investors North America Inc, trades as "Proactiveinvestors USA & Canada".


You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter.


You understand that the Site may contain opinions from time to time with regard to securities mentioned in other products, including company related products, and that those opinions may be different from those obtained by using another product related to the Company. You understand and agree that contributors may write about securities in which they or their firms have a position, and that they may trade such securities for their own account. In cases where the position is held at the time of publication and such position is known to the Company, appropriate disclosure is made. However, you understand and agree that at the time of any transaction that you make, one or more contributors may have a position in the securities written about. You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate.


From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.


You understand that we may be providing advertising and/or marketing services to companies mentioned on the site. A full list of companies that are paying for services from us, or our affiliated companies in the UK and Australia can be viewed here